14-day Premium Trial Subscription Sign Up For FreeGet Free

Cellectis S.A. Stock Forecast NASDAQ:CLLS

Price Target and Analyst Ratings

Most Recent Rating

On August 20, 2021 "Jonestrading" gave "$30.00" rating for CLLS. The price target was changed from $11.94 to 5.3%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-08-20 $30.00 Reiterated by Jonestrading $12.47 $11.94→5.3%
2021-06-03 Buy Initiated by Oppenheimer $14.36 $33.00
2021-06-01 Buy Reiterated by William Blair $16.35
2021-05-27 Buy Reiterated by Robert W. Baird $15.41 $39.00
2021-05-04 Buy - Neutral Reiterated by Guggenheim $16.99
2021-04-29 Buy Reiterated by Robert W. Baird $18.92 $39.00
2021-04-28 Buy - Neutral Downgraded by Guggenheim $18.87
2021-03-22 Neutral - Outperform Upgraded by Robert W. Baird $21.67 $23.00 → $39.00
2021-03-16 Neutral - Outperform Upgraded by Robert W. Baird $21.96 $23.00 → $39.00
2021-03-08 Buy Reiterated by William Blair $18.28
2020-11-18 Buy Reiterated by William Blair $21.02
2020-10-15 Outperform - Neutral Downgraded by Robert W. Baird $19.32
2020-08-19 Neutral - Buy Upgraded by Citigroup $19.10 $15.00 → $32.00
2020-08-06 Buy Reiterated by Oppenheimer $16.91 $33.00
2020-07-07 Outperform Target Lowered by Robert W. Baird $16.32 $28.00 → $21.00
2020-05-11 Outperform Initiated by Robert W. Baird $15.22
2020-05-07 Buy Reiterated by Oppenheimer $14.58 $35.00

CLLS Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -7.80% during the next 3 months and, with a 90% probability hold a price between $10.60 and $13.91 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-09-23 $11.47 $13.27 $15.07
2021-09-24 $11.45 $13.25 $15.05
2021-09-27 $11.43 $13.23 $15.03
2021-09-28 $11.41 $13.21 $15.01
2021-09-29 $11.39 $13.19 $14.99
2021-09-30 $11.37 $13.17 $14.97
2021-10-01 $11.35 $13.15 $14.94
2021-10-04 $11.33 $13.13 $14.92
2021-10-05 $11.31 $13.11 $14.90
2021-10-06 $11.29 $13.09 $14.88
2021-10-07 $11.27 $13.07 $14.86
2021-10-08 $11.25 $13.05 $14.84
2021-10-11 $11.23 $13.03 $14.82
2021-10-12 $11.21 $13.01 $14.80
2021-10-13 $11.19 $12.99 $14.78
2021-10-14 $11.17 $12.97 $14.76
2021-10-15 $11.15 $12.95 $14.74
2021-10-18 $11.13 $12.93 $14.72
2021-10-19 $11.11 $12.91 $14.70
2021-10-20 $11.09 $12.88 $14.68
2021-10-21 $11.07 $12.86 $14.66
2021-10-22 $11.05 $12.84 $14.64
2021-10-25 $11.03 $12.82 $14.62
2021-10-26 $11.01 $12.80 $14.60
2021-10-27 $10.99 $12.78 $14.58
2021-10-28 $10.97 $12.76 $14.56
2021-10-29 $10.95 $12.74 $14.54
2021-11-01 $10.93 $12.72 $14.52
2021-11-02 $10.91 $12.70 $14.50
2021-11-03 $10.89 $12.68 $14.48

About Cellectis S.A.

Cellectis SA Cellectis S.A., a gene-editing company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. Its lead product candidate is UCART19, an allogeneic T-cell product candidate for the treatment of CD19 expressing hematologic malignancies which develop in acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia. The company’s products also include UCART1... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT